Diluted EPS came in at $-158.32 (-316540.0% YoY).
Trailing eight quarters through Q1 2025
Common questions about Conduit Pharmaceuticals's Q1 2025 earnings report.
Conduit Pharmaceuticals (CDT) reported Q1 2025 earnings on May 15, 2025 before market open.
Conduit Pharmaceuticals reported diluted EPS of $-158.32 for Q1 2025.
Compared to the same quarter a year prior, diluted EPS declined 316540.0% from $-0.05.
You can read the 10-Q periodic report (0001641172-25-010405) directly on SEC EDGAR. The filing index links above go to sec.gov.